Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease
André Oberthuer, Patrick Warnat, Yvonne Kahlert, Frank Westermann, Rüdiger Spitz, Benedikt Brors, Barbara Hero, Roland Eils, Manfred Schwab, Frank Berthold, Matthias FischerVolume:
250
Year:
2007
Language:
english
Pages:
268
DOI:
10.1016/j.canlet.2006.10.016
File:
PDF, 1.54 MB
english, 2007